• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CONUT 评分与非小细胞肺癌的病理分级相关。

The CONUT score is associated with the pathologic grade in non-small cell lung cancer.

机构信息

Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Seiryomachi 4-1, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

出版信息

Surg Today. 2024 Dec;54(12):1437-1444. doi: 10.1007/s00595-024-02860-8. Epub 2024 May 6.

DOI:10.1007/s00595-024-02860-8
PMID:38709286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11582223/
Abstract

PURPOSE

Nutritional scores have been reported to be useful prognostic factors for various cancers. This study evaluated the usefulness of the preoperative controlling nutritional status (CONUT) score as a predictor of recurrence of non-small cell lung cancer (NSCLC).

METHODS

The present study included 422 patients with stage I-IIIA NSCLC who underwent complete resection at Tohoku University Hospital between January 2010 and December 2016. The patients were divided into the low-CONUT and high-CONUT groups based on their CONUT scores. Overall survival (OS), recurrence-free survival (RFS), and cumulative recurrence rates in the low- and high-CONUT groups were evaluated retrospectively.

RESULTS

One hundred forty-seven patients (34.8%) were assigned to the high-CONUT group. The high-CONUT group had a significantly worse performance status, pleural invasion, vascular invasion, and lung metastasis. In the whole cohort, the low-CONUT group showed better overall survival, recurrence-free survival, and a low cumulative recurrence rate in comparison to the high-CONUT group. There was no significant difference in prognosis or recurrence between the low- and high-CONUT groups after propensity score matching.

CONCLUSION

Patients with a high CONUT score may be at high risk of recurrence because of the high frequency of pleural invasion, vascular invasion, and lung metastasis.

摘要

目的

营养评分已被报道可作为多种癌症的有用预后因素。本研究评估了术前控制营养状况(CONUT)评分作为非小细胞肺癌(NSCLC)复发预测指标的有用性。

方法

本研究纳入了 2010 年 1 月至 2016 年 12 月在日本东北大学医院接受完全切除术的 422 例 I 期-IIIA 期 NSCLC 患者。根据 CONUT 评分,患者分为低 CONUT 和高 CONUT 组。回顾性评估低 CONUT 和高 CONUT 组的总生存(OS)、无复发生存(RFS)和累积复发率。

结果

147 例(34.8%)患者被分配到高 CONUT 组。高 CONUT 组的体能状态、胸膜侵犯、血管侵犯和肺转移的发生率明显更高。在整个队列中,与高 CONUT 组相比,低 CONUT 组的总生存、无复发生存和累积复发率更低。在倾向评分匹配后,低 CONUT 和高 CONUT 组之间的预后或复发无显著差异。

结论

由于胸膜侵犯、血管侵犯和肺转移的发生率较高,CONUT 评分较高的患者可能有较高的复发风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a6/11582223/7be1f85699ec/595_2024_2860_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a6/11582223/ffc1712635c5/595_2024_2860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a6/11582223/2eb9f5783f1c/595_2024_2860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a6/11582223/9e883ff14b86/595_2024_2860_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a6/11582223/7be1f85699ec/595_2024_2860_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a6/11582223/ffc1712635c5/595_2024_2860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a6/11582223/2eb9f5783f1c/595_2024_2860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a6/11582223/9e883ff14b86/595_2024_2860_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a6/11582223/7be1f85699ec/595_2024_2860_Fig4_HTML.jpg

相似文献

1
The CONUT score is associated with the pathologic grade in non-small cell lung cancer.CONUT 评分与非小细胞肺癌的病理分级相关。
Surg Today. 2024 Dec;54(12):1437-1444. doi: 10.1007/s00595-024-02860-8. Epub 2024 May 6.
2
The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.术前控制营养状况评分可预测Ⅰ期非小细胞肺癌患者根治性手术后的生存情况。
Anticancer Res. 2017 Feb;37(2):741-747. doi: 10.21873/anticanres.11372.
3
Preoperative Immune-Nutritional Abnormality Predicts Poor Outcome in Elderly Non-Small-Cell Lung Cancer Patients with Comorbidities.术前免疫营养异常预示合并症老年非小细胞肺癌患者预后不良。
Ann Thorac Cardiovasc Surg. 2020 Oct 21;26(5):240-247. doi: 10.5761/atcs.oa.19-00207. Epub 2020 Jan 29.
4
Prognostic impact of the pre-treatment controlling nutritional status score in patients with non-small cell lung cancer: A meta-analysis.治疗前控制营养状况评分对非小细胞肺癌患者预后的影响:一项荟萃分析。
Medicine (Baltimore). 2021 Jul 2;100(26):e26488. doi: 10.1097/MD.0000000000026488.
5
The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer.控制营养状态(CONUT)评分作为小细胞肺癌新型预后参数的意义。
Lung. 2020 Aug;198(4):695-704. doi: 10.1007/s00408-020-00361-2. Epub 2020 May 19.
6
Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.术前控制营养状况(CONUT)评分对接受肝细胞癌肝切除术患者的预后意义:一项多机构研究。
Ann Surg Oncol. 2018 Oct;25(11):3316-3323. doi: 10.1245/s10434-018-6672-6. Epub 2018 Jul 26.
7
Prognostic Significance of CONUT Score in Elderly NSCLC.CONUT 评分在老年 NSCLC 中的预后意义。
Ann Thorac Cardiovasc Surg. 2024;30(1). doi: 10.5761/atcs.oa.24-00009.
8
Pathological Pleural Invasion is a Risk Factor for Late Recurrence in Long-Term Survivors of Non-small Cell Lung Cancer after Complete Resection.病理性胸膜侵犯是非小细胞肺癌完全切除术后长期生存者晚期复发的危险因素。
Ann Surg Oncol. 2024 Aug;31(8):5038-5046. doi: 10.1245/s10434-024-15279-9. Epub 2024 Apr 22.
9
Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.术前预后营养指数对病理I期非小细胞肺癌术后复发的预测影响。
Lung Cancer. 2016 Aug;98:15-21. doi: 10.1016/j.lungcan.2016.05.010. Epub 2016 May 16.
10
Prediction of postoperative pulmonary complications using preoperative controlling nutritional status (CONUT) score in patients with resectable non-small cell lung cancer.术前控制营养状况(CONUT)评分预测可切除性非小细胞肺癌患者术后肺部并发症。
Sci Rep. 2020 Jul 24;10(1):12385. doi: 10.1038/s41598-020-68929-9.

本文引用的文献

1
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.新辅助纳武利尤单抗联合化疗治疗可切除肺癌。
N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11.
2
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.辅助阿特珠单抗治疗辅助化疗后切除的 IB-IIIA 期非小细胞肺癌(IMpower010):一项随机、多中心、开放标签、III 期临床试验。
Lancet. 2021 Oct 9;398(10308):1344-1357. doi: 10.1016/S0140-6736(21)02098-5. Epub 2021 Sep 20.
3
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
CheckMate 017 和 057 随机、III 期临床试验的 5 年结果:纳武利尤单抗对比多西他赛用于先前治疗的非小细胞肺癌。
J Clin Oncol. 2021 Mar 1;39(7):723-733. doi: 10.1200/JCO.20.01605. Epub 2021 Jan 15.
4
Prognostic Significance of the Preoperative Controlled Nutritional Status Score in Lung Cancer Patients Undergoing Surgical Resection.术前控营养状态评分对肺癌患者手术切除预后的意义。
Nutr Cancer. 2021;73(11-12):2211-2218. doi: 10.1080/01635581.2020.1850814. Epub 2020 Dec 15.
5
The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer.术前预后营养指数是高级别浆液性卵巢癌的预测和预后因素。
BMC Cancer. 2018 Sep 10;18(1):883. doi: 10.1186/s12885-018-4732-8.
6
Impact of Prognostic Nutritional Index on Overall Survival for Patients with Metastatic Urothelial Carcinoma.预后营养指数对转移性尿路上皮癌患者总生存期的影响
J Cancer. 2018 Jun 14;9(14):2466-2471. doi: 10.7150/jca.25061. eCollection 2018.
7
The influence of diet on anti-cancer immune responsiveness.饮食对癌症免疫反应的影响。
J Transl Med. 2018 Mar 20;16(1):75. doi: 10.1186/s12967-018-1448-0.
8
Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma.控制营养状况评分对肺鳞状细胞癌切除术后的预后影响
J Thorac Dis. 2017 Sep;9(9):2942-2951. doi: 10.21037/jtd.2017.07.108.
9
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)作为接受纳武单抗治疗的非小细胞肺癌(NSCLC)患者的预后标志物。
Lung Cancer. 2017 Sep;111:176-181. doi: 10.1016/j.lungcan.2017.07.024. Epub 2017 Jul 24.
10
Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection.控制营养状况(CONUT)评分是胃癌患者根治性切除术后的预后标志物。
Gastric Cancer. 2018 Mar;21(2):204-212. doi: 10.1007/s10120-017-0744-3. Epub 2017 Jun 27.